Dental Implant Therapy on a Patient With von Willebrand Disease: A Case Study

被引:6
作者
Kang, Michael [1 ]
Kang, Philip [1 ]
机构
[1] Columbia Univ, Coll Dent Med, Sect Oral Diagnost & Rehabil Sci, Div Periodont, PH7E 124,630 W 168 St, New York, NY 10032 USA
关键词
anticoagulants; hemostasis; oral surgery; periodontal surgery; SURGERY;
D O I
10.1097/ID.0000000000000821
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: Von Willebrand disease (vWD) is the most common hereditary disorder affecting coagulation. Patients with this disorder are at a higher risk of postoperative complications after dental surgery. This article discusses the successful treatment for a patient with vWD undergoing implant therapy. Case Description: A young 21-year-old patient with vWD lost tooth #30 because of caries and required implant therapy. Through collaboration with a hematologist administering prophylactic desmopressin (DDAVP), the implant surgery was performed without any postoperative complications. The implant successfully integrated and was restored into function. The successful outcome met expectations after careful planning and execution. Practical Implications: Collaboration with the appropriate medical providers, as well as treatment modifications for surgical procedures during implant therapy, is necessary for successful treatment of a patient with von Willebrand disorder.
引用
收藏
页码:599 / 601
页数:3
相关论文
共 50 条
  • [21] New concepts in Von Willebrand disease
    Sadler, JE
    ANNUAL REVIEW OF MEDICINE, 2005, 56 : 173 - +
  • [22] Fibrinolysis and von Willebrand factor in Alzheimer's disease and vascular dementia - a case-referent study
    Hagnelius, Nils-Olof
    Boman, Kurt
    Nilsson, Torbjorn K.
    THROMBOSIS RESEARCH, 2010, 126 (01) : 35 - 38
  • [23] Surgery in patients with von Willebrand disease
    Zulfikar, Bulent
    Koc, Basak
    Ak, Gulsum
    Dikici, Fatih
    Karaman, Ihsan
    Atalar, Ata Can
    Bezgal, Fikret
    BLOOD COAGULATION & FIBRINOLYSIS, 2016, 27 (07) : 812 - 816
  • [24] Structure and function of von Willebrand factor: the protein that is deficient and/or abnormal in inherited von Willebrand disease
    Hassan, Md Imtaiyaz
    Saxena, Aditya
    Ahmad, Faizan
    BLOOD COAGULATION & FIBRINOLYSIS, 2012, 23 (01) : 11 - 22
  • [25] Acquired von Willebrand Syndrome in a Patient Undergoing Extracorporeal Membrane Oxygenation: A Case Report
    Ettamri Ouaaba, Asmae
    Behar Lagares, Raquel
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [26] Utility of thromboelastography for the diagnosis of von Willebrand disease
    Regling, Katherine
    Kakulavarapu, Srikruthi
    Thomas, Ronald
    Hollon, Wendy
    Chitlur, Meera B.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (07)
  • [27] Safety of dental implant surgery in patients undergoing anticoagulation therapy: a prospective case-control study
    Bacci, Christian
    Berengo, Mario
    Favero, Lorenzo
    Zanon, Ezio
    CLINICAL ORAL IMPLANTS RESEARCH, 2011, 22 (02) : 151 - 156
  • [28] Gastrointestinal angiodysplasia and bleeding in von Willebrand disease
    Franchini, Massimo
    Mannucci, Pier Mannuccio
    THROMBOSIS AND HAEMOSTASIS, 2014, 112 (03) : 427 - 431
  • [29] The Course of von Willebrand Factor and Factor VIII Activity in Patients with von Willebrand Disease during Pregnancy
    Delbrueck, Christiane
    Miesbach, Wolfgang
    ACTA HAEMATOLOGICA, 2019, 142 (02) : 71 - 78
  • [30] Population pharmacokinetics of the von Willebrand factor-factor VIII interaction in patients with von Willebrand disease
    Bukkems, Laura H.
    Heijdra, Jessica M.
    de Jager, Nico C. B.
    Hazendonk, Hendrika C. A. M.
    Fijnvandraat, Karin
    Meijer, Karina
    Eikenboom, Jeroen C. J.
    Laros-van Gorkom, Britta A. P.
    Leebeek, Frank W. G.
    Cnossen, Marjon H.
    Mathot, Ron A. A.
    BLOOD ADVANCES, 2021, 5 (05) : 1513 - 1522